Related Experiment Video
Updated: Jul 7, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Gynaecologic surgery from uncertainty to science: evolution of randomized control trials
Tara J Selman1, Neil P Johnson, Javier Zamora
1Department of Reproductive and Child Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. taraselman@blueyonder.co.uk
Human Reproduction (Oxford, England)
|January 30, 2008
Summary
Research in gynaecologic surgery has improved, with better reporting of randomized controlled trials (RCTs) after the CONSORT statement. This enhances the evidence base for surgical interventions, despite challenges in practitioner participation.
Area of Science:
- Gynaecologic Surgery
- Clinical Evidence
- Research Methodology
Background:
- Medical and surgical practices require reliable clinical evidence.
- Randomized controlled trials (RCTs) for surgical interventions face challenges.
- Assessing progress in the evidence base for gynaecologic surgery is crucial.
Purpose of the Study:
- To evaluate advancements in establishing the evidence base for surgical interventions in gynaecology.
- To determine if research quality and reporting have improved over time.
Main Methods:
- Systematic review of relevant Cochrane reviews and individual RCTs.
- Statistical analysis including Chi-squared tests, meta-regression, and logistic regression.
- Comparison of trial quality and effect sizes pre- and post-Consolidated Standards of Reporting Trials (CONSORT) statement.
Main Results:
- The proportion of studies reporting allocation concealment significantly increased post-CONSORT statement (P = 0.002).
- A trend towards improved precision in treatment effect estimates was observed over time.
- A statistically significant reduction in the size of treatment effect was noted over time (P = 0.04).
Conclusions:
- Gynaecologic surgical practice is benefiting from an improved research base.
- Enhanced research quality contributes to a more reliable evidence base in gynaecology.
- Despite challenges, progress in evidence generation for gynaecologic surgery is evident.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...